Get the Stockscreener App
28.03
0.85%
-0.24
Omnicell Inc stock is traded at $28.03, with a volume of 695.61K.
It is down -0.85% in the last 24 hours and down -2.61% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$28.27
Open:
$28.59
24h Volume:
695.61K
Relative Volume:
1.06
Market Cap:
$1.46B
Revenue:
$1.08B
Net Income/Loss:
$-20.76M
P/E Ratio:
-60.93
EPS:
-0.46
Net Cash Flow:
$151.63M
1W Performance:
-4.17%
1M Performance:
-2.61%
6M Performance:
-37.68%
1Y Performance:
-0.81%
1-Day Range:
$27.99
$28.62
1-Week Range:
$27.99
$29.64
52-Week Range:
$22.66
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
28.03 | 1.46B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
280.08 | 46.43B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
68.31 | 12.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
57.36 | 10.79B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
101.30 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.69 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Automated Medication Compounding System Market Generated - openPR.com
Q1 Rundown: Omnicell (NASDAQ:OMCL) Vs Other Healthcare Technology for Providers Stocks - Yahoo Finance
Pharmacy Automation Devices Market Set to Witness Significant - openPR.com
Learn to Evaluate (OMCL) using the Charts - news.stocktradersdaily.com
Robotic Pharmacy Automation System Market Is Booming So Rapidly - openPR.com
Do Options Traders Know Something About Omnicell Stock We Don't? - The Globe and Mail
Omnicell Inc. to Pay $4.3 Million to Settle VA Overbilling Allegations - USA Herald
VA Contractor To Pay $4.3M To Resolve Overbilling Claims - Law360
Unit Dose Drug Delivery Systems Market Booming with Hospital Safety Initiatives | Omnicell Inc., Baxter International - openPR.com
New Technology Developments in Robotic Dispensing System - openPR.com
Omnicell Deploys Healthcare Automation to Ease Staff Strain and Elevate Patient Care - MarketScale
Omnicell Tackles Medication Inefficiency with RFID, AI, and a Vision for the Autonomous Pharmacy - MarketScale
Self-service Pharmacies Market Growth Expected to See Next Level | MedAvail, Omnicell, BD Rowa - openPR.com
Is it Apt to Retain Omnicell Stock in Your Portfolio Now? - The Globe and Mail
omnicell announces cfo transition with separation agreement - Investing.com
omnicell announces cfo transition with separation agreement By Investing.com - Investing.com India
Omnicell (OMCL) Up 27% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Adherence Packaging Market 2025- 2032 Overview: Share, Size, - openPR.com
OMCL: Upcoming Analyst Meetings Could Influence Stock Performanc - GuruFocus
OMCL: Upcoming Analyst Meetings Could Influence Stock Performance | OMCL Stock News - GuruFocus
Pharmacy Automation Market Overall Study Report 2025-2032 | - openPR.com
High Volume Dispensing Systems Market Report: Insights, - openPR.com
Two Sigma Advisers LP Sells 2,600 Shares of Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell opens innovation lab in Texas - MSN
Central Fill Pharmacy Automation Market Top Companies Study -Omnicell, Inc., McKesson Corporation, ScriptPro LLC - openPR.com
Pharmacy Automation Market in 2025-2032 Detailed Study - openPR.com
Opportunities for the Global Medication Management Solutions - openPR.com
BNP Paribas Financial Markets Lowers Position in Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell, Inc. (NASDAQ:OMCL) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know - Yahoo
Ameriprise Financial Inc. Trims Stake in Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell stock holds $40 target amid tariff cuts By Investing.com - Investing.com Nigeria
Omnicell stockholders approve equity plan amendment - Investing.com Australia
Omnicell stock rises on prospects of improved profitability due to U.S.-China trade truce, buyback - MSN
Omnicell stockholders approve equity plan amendment By Investing.com - Investing.com Nigeria
Omnicell Raises Earnings Forecast Amid Lower China Tariffs - Finimize
Omnicell Stockholders Approve Key Proposals at Annual Meeting - TipRanks
What Analysts Are Saying About Omnicell Stock - Benzinga
Omnicell (OMCL): B of A Securities Raises Price Target to $34 | - GuruFocus
Omnicell (OMCL): Wells Fargo Raises Price Target to $37, Maintains Overweight Rating | OMCL Stock News - GuruFocus
Omnicell (OMCL): B of A Securities Raises Price Target to $34 | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Raised by Piper Sandler | OMCL Stoc - GuruFocus
Piper Sandler Adjusts Omnicell Price Target to $57 From $46, Maintains Overweight Rating - marketscreener.com
Omnicell (OMCL) Target Price Raised by Piper Sandler | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Increased Following Share Buyback N - GuruFocus
Wells Fargo Boosts Price Target for Omnicell (OMCL) Amid Improved Outlook | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Increased Following Share Buyback News | OMCL Stock News - GuruFocus
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Omnicell Inc Stock (OMCL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
2.80%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):